Stem Cell Therapy Market by Type (Allogeneic, Autologous), Therapeutic Application (Musculoskeletal, Wound & Injury, CVD, Surgery, and aGVHD), Cell Source (Adipose tissue, Bone Marrow, Neural, Embryo/Cord Blood derived) - Global Forecasts to 2021

  • ID: 4085953
  • Report
  • Region: Global
  • 123 Pages
  • Markets and Markets
1 of 5
Global Stem Cell Therapy Market Estimated to Grow at a CAGR of 11.0% During 2016 to 2021 to Reach USD 145.8 Million by 2021

FEATURED COMPANIES

  • Allosource
  • Anterogen Co., Ltd.
  • Medipost Co., Ltd.
  • Nuvasive, Inc.
  • Osiris Therapeutics, Inc.
  • Pharmicell Co., Ltd.
  • MORE

Growth in the global stem cell therapy market is driven by factors such as the growing awareness of the therapeutic potency of stem cells in effective disease management, development of advanced genome-based cell analysis techniques, increasing public-private investments for development of stem cell therapies, identification of new stem cell lines, and developments in infrastructure related to stem cell banking and processing. In addition, countries such as Japan, South Korea, and China are offering new growth opportunities for players operating in this market. The North American region is expected to command the largest share in the stem cell therapy market in 2016.

Based on the type of therapy, the allogeneic stem cell therapy segment is estimated to command the larger share of the global stem cell therapy market in 2016. This growth can be attributed to the growing availability of allogeneic stem cell therapy products, wider therapeutic applications of allogeneic stem cells, easier production scale-up due to easy availability of sources of stem cells, and growing number of clinical trials of allogeneic stem cell therapies as compared to autologous stem cell therapies.

The stem cell therapy market is niche industry with a growing number of global and local companies involved in the development and commercialization of stem cell therapy products. Osiris Therapeutics, Inc. (U.S.), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), and Pharmicell Co., Ltd. (South Korea) were the leading players in the global stem cell therapy market in 2015. New product launches and approvals; expansions; and partnerships and agreements are the major strategies adopted by most of the market players to achieve growth in the stem cell therapy market during 2013-2016.

Research Coverage:

This report studies stem cell therapy market based on type of therapy (allogeneic and autologous). These stem cell therapies are used for the treatment of various diseases (including musculoskeletal disorders, wound healing, CVDs, and GI diseases, among others). The report also studies, the factors (such as drivers, restraints, opportunities, and challenges) which affect the market growth in a positive and negative manner. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report forecasts the revenue of the market segments with respect to four main regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. The stem cell therapy market report strategically profiles the key players who are involved in the manufacturing and commercialization of stem cell therapy products and comprehensively analyze their market ranking and core competencies. The report tracks and analyzes competitive developments such as new product launches and enhancements; expansions; and partnerships and agreements in the stem cell therapy market.

Reasons to Buy the Report:

From an insight perspective, this research report focuses on various levels of analysis-market share analysis of the top players and company profiles, which together comprise and discuss basic views on the competitive landscape; emerging and high-growth segments of the stem cell therapy market; and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on products offered by the top 10 players in the stem cell therapy market. The report analyzes the stem cell therapy market by type, therapeutic application, cell source, and region.
  • Product Development/Innovation: Detailed insights on research and development activities, developmental product pipeline, and new product launches in the stem cell therapy market.
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various stem cell therapy products across four geographies (North America, Europe, Asia-Pacific, and the Rest of the World).
  • Competitive Assessment: Assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the stem cell therapy market.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Allosource
  • Anterogen Co., Ltd.
  • Medipost Co., Ltd.
  • Nuvasive, Inc.
  • Osiris Therapeutics, Inc.
  • Pharmicell Co., Ltd.
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
1.3.3 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown And Data Triangulation
2.4 Research Assumptions

3 Executive Summary
3.1 Introduction
3.2 Conclusion

4 Premium Insights
4.1 Stem Cell Therapy Market Overview
4.2 Regional Analysis: Stem Cell Therapy Market,  By Type, 2016 Vs. 2021 (USD Million)
4.3 Global Stem Cell Therapy Market, By Therapeutic Application, 2016-2021 (USD Million)
4.4 Regional Analysis: Stem Cell Therapy Market,  By Cell Source, 2016 Vs. 2021 (USD Million)
 
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Growth Drivers
5.2.1.1 Growing Awareness Related to the Therapeutic Potency of Stem Cells in Effective Disease Management
5.2.1.2 Development of Advanced Genome-Based Cell Analysis Techniques
5.2.1.3 Increasing Public-Private Investments for the Development of Stem Cell Therapies
5.2.1.4 Development in Infrastructure Related to Stem Cell Banking And Processing
5.2.2 Market Restraints
5.2.2.1 Unclear Regulatory Guidelines for Product Development And Commercialization
5.2.2.2 Socio-Ethical Issues Related to the Use of Escs in Disease Treatment
5.2.3 Market Growth Opportunities
5.2.3.1 Supportive Regulations Across Developing Countries
5.2.3.2 Emergence of Ipscs As An Effective Alternative to Escs
5.2.4 Market Challenges
5.2.4.1 Technical Limitations Related to Production Scale-Up
5.3 Regulatory Landscape
5.3.1 North America
5.3.2 Europe
5.3.3 Asia-Pacific
5.3.4 Rest of the World

6 Industry Insights
6.1 Introduction
6.2 Supply Chain Analysis
6.2.1 Key Stakeholders
6.2.2 Key Influencers
6.3 Pipeline Analysis
6.3.1 Pipeline Analysis: Based On Phase of Clinical Study
6.3.2 Pipeline Analysis: Based On Type
6.3.3 Pipeline Analysis: Based On the Cell Line Used

7 Global Stem Cell Therapy Market, By Type
7.1 Introduction
7.2 Allogeneic Stem Cell Therapy Market, By Application
7.2.1 Musculoskeletal Disorders
7.2.2 Wounds And Injuries
7.2.3 Surgeries
7.2.4 Acute Graft-Versus-Host Disease (Agvhd)
7.2.5 Other Applications
7.3 Autologous Stem Cell Therapy Market, By Application
7.3.1 Wounds And Injuries
7.3.2 Cardiovascular Diseases
7.3.3 Gastrointestinal Diseases
7.3.4 Other Applications

8 Global Stem Cell Therapy Market,  By Therapeutic Application
8.1 Introduction
8.2 Musculoskeletal Disorders
8.3 Wounds And Injuries
8.4 Cardiovascular Diseases
8.5 Surgeries
8.6 Gastrointestinal Diseases
8.7 Other Applications

9 Global Stem Cell Therapy Market, By Cell Source
9.1 Introduction
9.2 Adipose Tissue-Derived Mesenchymal Stem Cells
9.3 Bone Marrow-Derived Mesenchymal Stem Cells
9.4 Cord Blood/Embryonic Stem Cells
9.5 Other Cell Sources

10 Stem Cell Therapy Market, By Region
10.1 Introduction
10.2 North America
10.3 Europe
10.4 Asia-Pacific
10.5 Rest of the World (Row)

11 Competitive Landscape
11.1 Overview
11.2 Market Ranking
11.3 Strategic Benchmarking
11.3.1 Product Development And Commercialization
11.4 Competitive Scenario
11.5 Recent Developments
11.5.1 Product Launches And Approvals
11.5.2 Expansions
11.5.3 Agreements, Collaborations, And Partnerships
 
12 Company Profiles
12.1 Introduction
(Overview, Financials, Products & Services, Strategy, And Developments)*
12.2 Osiris Therapeutics, Inc.
12.3 Medipost Co., Ltd.
12.4 Anterogen Co., Ltd.
12.5 Pharmicell Co., Ltd.
12.6 Holostem Terapie Avanzate Srl
12.7 Jcr Pharmaceuticals Co., Ltd.
12.8 Nuvasive, Inc.
12.9 Rti Surgical, Inc.
12.10 Allosource
*Details On Overview, Financials, Product & Services, Strategy, And Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Subscription Portal
13.4 Introducing Rt: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports
13.7 Author Details

List of Tables
Table 1 Few of the Recently Launched Cell Analysis Products (2015-2017)
Table 2 North America: Regulatory Landscape for Stem Cell Therapy (As of 2016)
Table 3 Europe: Regulatory Landscape for Stem Cell Therapy (As of 2016)
Table 4 Asia-Pacific: Regulatory Landscape for Stem Cell Therapy (As of 2016)
Table 5 Row: Regulatory Landscape for Stem Cell Therapy (As of 2016)
Table 6 Global Stem Cell Therapy Market Size, By Type, 2014-2021 (USD Million)
Table 7 Global Allogeneic Stem Cell Therapy Market Size, By Application,  2014-2021 (USD Million)
Table 8 Global Allogeneic Stem Cell Therapy Market Size, By Region,  2014-2021 (USD Million)
Table 9 Allogeneic Stem Cell Therapy Market Size for Musculoskeletal Disorders, By Region, 2014-2021 (USD Million)
Table 10 Allogeneic Stem Cell Therapy Market Size for Wounds And Injuries,  By Region, 2014-2021 (USD Million)
Table 11 Allogeneic Stem Cell Therapy Market Size for Surgeries, By Region,  2014-2021 (USD Million)
Table 12 Allogeneic Stem Cell Therapy Market Size for Acute Graft-Versus-Host Disease, By Region, 2014-2021 (USD Million)
Table 13 Allogeneic Stem Cell Therapy Market Size for Other Applications, By Region, 2014-2021 (USD Million)
Table 14 Global Autologous Stem Cell Therapy Market Size, By Application,  2014-2021 (USD Million)
Table 15 Global Autologous Stem Cell Therapy Market Size, By Region,  2014-2021 (USD Million)
Table 16 Autologous Stem Cell Therapy Market for Wounds And Injuries, By Region,  2014-2021 (USD Million)
Table 17 Autologous Stem Cell Therapy Market Size for Cardiovascular Diseases,  By Region, 2014-2021 (USD Million)
Table 18 Autologous Stem Cell Therapy Market Size for Gastrointestinal Diseases,  By Region, 2014-2021 (USD Million)
Table 19 Autologous Stem Cell Therapy Market Size for Other Applications, By Region, 2014-2021 (USD Million)
Table 20 Global Stem Cell Therapy Market Size, By Therapeutic Application,  2014-2021 (USD Million)
Table 21 Stem Cell Therapy Market Size for Musculoskeletal Disorders, By Region, 2014-2021 (USD Million)
Table 22 Stem Cell Therapy Market Size for Wounds And Injuries, By Region,  2014-2021 (USD Million)
Table 23 Stem Cell Therapy Market Size for Cardiovascular Diseases, By Region,  2014-2021 (USD Million)
Table 24 Stem Cell Therapy Market Size for Surgeries, By Region,  2014-2021 (USD Million)
Table 25 Stem Cell Therapy Market Size for Gastrointestinal Diseases, By Region, 2014-2021 (USD Million) 71
Table 26 Stem Cell Therapy Market Size for Other Applications, By Region,  2014-2021 (USD Million)
Table 27 Global Stem Cell Therapy Market Size, By Cell Source,  2014-2021 (USD Million)
Table 28 Stem Cell Therapy Market Size for Adipose Tissue-Derived Mscs, By Region, 2014-2021 (USD Million)
Table 29 Stem Cell Therapy Market Size for Bone Marrow-Derived Mscs, By Region, 2014-2021 (USD Million)
Table 30 Stem Cell Therapy Market Size for Cord Blood/Embryonic Stem Cells,  By Region, 2014-2021 (USD Million)
Table 31 Stem Cell Therapy Market Size for Other Cell Sources, By Region,  2014-2021 (USD Million)
Table 32 Stem Cell Therapy Market Size, By Region, 2014-2021 (USD Million)
Table 33 North America: Stem Cell Therapy Market Size, By Type, 2014-2021 (USD Million)
Table 34 North America: Stem Cell Therapy Market Size, By Therapeutic Applications,  2014-2021 (USD Million)
Table 35 North America: Stem Cell Therapy Market Size, By Cell Source, 2014-2021 (USD Million)
Table 36 Europe: Stem Cell Therapy Market Size, By Type, 2014-2021 (USD Million)
Table 37 Europe: Stem Cell Therapy Market Size, By Therapeutic Application,  2014-2021 (USD Million)
Table 38 Europe: Stem Cell Therapy Market Size, By Cell Source, 2014-2021 (USD Million)
Table 39 Asia-Pacific: Stem Cell Therapy Market Size, By Type, 2014-2021 (USD Million)
Table 40 Asia-Pacific: Stem Cell Therapy Market Size, By Therapeutic Application,  2014-2021 (USD Million)
Table 41 Asia-Pacific: Stem Cell Therapy Market Size, By Cell Source, 2014-2021 (USD Million)
Table 42 Row: Stem Cell Therapy Market Size, By Type, 2014-2021 (USD Million)
Table 43 Row: Stem Cell Therapy Market Size, By Therapeutic Application, 2014-2021 (USD Million)
Table 44 Row: Stem Cell Therapy Market Size, By Cell Source, 2014-2021 (USD Million)
Table 45 Top Product Launches And Approvals (2013-2016)
Table 46 Top Expansions (2013 - 2016)
Table 47 Top Agreements, Collaborations, And Partnerships (2013-2016)
Table 48 Osiris Therapeutics, Inc.: Stem Cell Therapy Products Offered
Table 49 Osiris Therapeutics, Inc.: Stem Cell Therapy Product Pipeline
Table 50 Medipost Co., Ltd.: Stem Cell Therapy Products Offered
Table 51 Medipost Co., Ltd.: Stem Cell Therapy Product Pipeline
Table 52 Anterogen Co., Ltd.: Stem Cell Therapy Products Offered
Table 53 Anterogen Co., Ltd.: Stem Cell Therapy Product Pipeline
Table 54 Pharmicell Co., Ltd.: Stem Cell Therapy Products Offered
Table 55 Pharmicell Co., Ltd.: Stem Cell Therapy Product Pipeline
Table 56 Holostem Terapie Avanzate Srl: Stem Cell Therapy Products Offered
Table 57 Jcr Pharmaceuticals Co., Ltd.: Stem Cell Therapy Products Offered
Table 58 Nuvasive, Inc.: Stem Cell Therapy Products Offered
Table 59 Rti Surgical, Inc.: Stem Cell Therapy Products Offered
Table 60 Allosource: Stem Cell Therapy Products Offered

List of Figures
Figure 1 Research Design
Figure 2 Bottom-Up Approach
Figure 3 Top-Down Approach
Figure 4 Data Triangulation
Figure 5 Assumptions for the Study
Figure 6 Allogeneic Stem Cell Therapy Dominates the Stem Cell Therapy Market in 2016
Figure 7 Musculoskeletal Disorders Commands the Largest Share of the Stem Cell Therapy Market in 2016
Figure 8 Adipose Tissue-Derived Mscs Will Continue to Dominate the Stem Cell Therapy Market Till 2021
Figure 9 Stem Cell Therapy Market Share, By Region
Figure 10 Emerging Countries Offer High-Growth Opportunities to Players in the Stem Cell Therapy Market
Figure 11 Allogeneic Stem Cell Therapy to Dominate the Global Stem Cell Therapy Market During Forecast Period
Figure 12 Musculoskelatal Disorders Segment to Dominate the Global Stem Cell Therapy Market During Forecast Period
Figure 13 Adipose Tissue-Derived Cell Source Segment to Dominate the Stem Cell Therapy Market During Forecast Period
Figure 14 Growing Public Awareness Related to Therapeutic Potency of Stem Cells is Augmenting the Market Growth During the Study Period
Figure 15 Market Players Prefer Both Direct & Indirect Distribution Strategies for Stem Cell Therapy Products Across Major Geographies
Figure 16 Majority of Stem Cell Therapy Candidate Products Are in Preclinical Phase, Followed By Phase 1 & Phase 1/2
Figure 17 Allogeneic Stem Cell Therapy Pipeline Products Account for a Larger Share of the Overall Stem Cell Therapy Products Under Development
Figure 18 Allogeneic Stem Cell Therapy Pipeline Products: Based On Study Phases
Figure 19 Autologous Stem Cell Therapy Pipeline Products: Based On Study Phases
Figure 20 Bone Marrow-Derived Mesenchymal Stem Cells Are Preferred for Stem Cell Therapy Development
Figure 21 Allogeneic Stem Cell Therapy to Dominate the Global Stem Cell Therapy Market Till 2021
Figure 22 Musculoskelatal Disorders to Dominate the Allogeneic Stem Cell Therapy Market Till 2021
Figure 23 Wounds And Injuries Market to Dominate the Autologous Stem Cell Therapy Market Till 2021
Figure 24 Musculoskelatal Disorders Segment to Dominate Global Stem Cell Therapy Market Till 2021
Figure 25 Adipose Tissue-Derived Mesenchymal Stem Cells to Dominate the Global Stem Cell Therapy Market Till 2021
Figure 26 North America: Stem Cell Therapy Market Snapshot
Figure 27 Europe: Stem Cell Therapy Market Snapshot
Figure 28 Asia Pacific: Stem Cell Therapy Market Snapshot
Figure 29 Row: Stem Cell Therapy Market Snapshot
Figure 30 Global Stem Cell Therapy Market Ranking (2015)
Figure 31 Product Development And Commercialization: the Key Growth Strategy Adopted By Stem Cell Therapy Market Players (2013-2016)
Figure 32 Product Launches And Enhancements: Key Strategy Adopted  By Majority of Key Players During Study Period
Figure 33 Geographic Revenue Mix of the Top Five Players (2015)
Figure 34 Medipost Co., Ltd.: Company Snapshot (2015)
Figure 35 Jcr Pharmaceuticals Co., Ltd.: Company Snapshot (2015)
Figure 36 Nuvasive, Inc.: Company Snapshot (2015)
Figure 37 Rti Surgical, Inc.: Company Snapshot (2015)

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Allosource
  • Anterogen Co., Ltd.
  • Medipost Co., Ltd.
  • Nuvasive, Inc.
  • Osiris Therapeutics, Inc.
  • Pharmicell Co., Ltd.
  • MORE

The global stem cell therapy market is expected to reach USD 145.8 Million by 2021, growing at a CAGR of 11.0% during the forecast period. Factors such as the growing awareness related to the therapeutic potency of stem cells in disease management, ongoing development of advanced genome-based cell analysis techniques, increasing public-private investments for stem cell research and product development, identification of new stem cell lines, and developments in infrastructure for stem cell banking and processing are driving the growth of the global market. However, factors such as unclear regulatory guidelines related to the development & commercialization of stem cell therapy products and socio-ethical issues related to the adoption of ESCs in disease treatment are restraining the growth of this market. In addition to this, technical limitations related to production scale-up pose a key challenge for players operating in this market.

On the basis of type, the global market is divided into two major categories, namely, allogeneic stem cell therapy and autologous stem cell therapy. On the basis of application, the allogeneic stem cell therapy market is further divided into musculoskeletal disorders, wounds and injuries, surgeries, acute Graft-Versus-Host Disease (aGVHD), and other applications. On the basis of application, the autologous stem cell therapy market is categorized into wounds and injuries, cardiovascular diseases, gastrointestinal diseases, and other applications. The allogenic stem cell therapy segment is expected to grow at the highest CAGR during the forecast period, owing to the rising commercialization of allogeneic stem cell therapy products, wider therapeutic applications of allogeneic stem cells, easy production scale-up process, and growing number of clinical trials related to allogeneic stem cell therapies.

On the basis of region, this market is classified into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, the global stem cell therapy market is expected to be dominated by North America. Also, this region is expected to be the fastest-growing region during the forecast period. Factors such as growing awareness related to the therapeutic potency of stem cells, increasing number of clinical trials for stem cell-based products, and increasing public-private funding & research grants are driving the growth of this market in the North American region.

New product launches and approvals are the key growth strategies adopted by major players to strengthen their positions in the global market. Moreover, strategies such as expansions as well as partnerships and agreements were also adopted by several market players to expand their R&D capabilities and geographic presence in the global market.

As of 2015, Osiris Therapeutics, Inc. (U.S.), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), Pharmicell Co., Ltd. (South Korea), Holostem Terapie Avanzate S.r.l. (Italy), JCR Pharmaceuticals Co., Ltd. (Japan), NuVasive, Inc. (U.S.), RTI Surgical, Inc. (U.S.), and AlloSource (U.S.) were some of the key players operating in the global stem cell therapy market.

Note: Product cover images may vary from those shown
5 of 5
  • Allosource
  • Anterogen Co., Ltd.
  • Holostem Terapie Avanzate Srl
  • JCR Pharmaceuticals Co., Ltd.
  • Medipost Co., Ltd.
  • Nuvasive, Inc.
  • Osiris Therapeutics, Inc.
  • Pharmicell Co., Ltd.
  • RTI Surgical, Inc.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll